颈动脉体瘤假阳性摄碘模拟分化型甲状腺癌淋巴结转移:SPECT/CT的鉴别价值
本文报道一名50岁女性滤泡变异型乳头状甲状腺癌患者,治疗后8年偶然发现颈动脉体瘤伴轻度摄碘,SPECT/CT将摄取定位于颈动脉体瘤而非淋巴结转移。该病例提示功能显像需与结构显像联合判读,避免将非特异性摄碘误判为转移而致不必要治疗。
要点
- 颈动脉体瘤通常生长抑素受体显像阳性,而非摄碘阳性。
- 分化型甲状腺癌随访中,摄碘灶需SPECT/CT定位排除假阳性。
- 功能与结构显像联合可避免误判转移和不必要治疗。
核心结论
- 颈动脉体瘤可表现为轻度摄碘的假阳性灶,模拟分化型甲状腺癌淋巴结转移。
研究设计与样本
- 单病例报告:50岁女性滤泡变异型乳头状甲状腺癌,治疗后8年 incidental 发现颈动脉体瘤。
临床怎么用
- 摄碘灶判读时应结合SPECT/CT定位,与结构影像对照,避免误判为转移。
局限性
- 单病例报告,结论的外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Carotid body tumors (CBTs) are uncommon neuroendocrine neoplasms which typically demonstrate avidity on somatostatin receptor-based imaging rather than radioiodine studies. We report a 50-year-old woman with follicular variant papillary thyroid carcinoma who, eight years post-treatment, developed a CBT incidentally demonstrating mild radioiodine uptake. SPECT/CT localized this unexpected uptake to the CBT, representing a rare false-positive finding. This case underscores the importance of correlating functional imaging with structural imaging to avoid misinterpretation of nonspecific radioiodine uptake as metastatic disease and prevent unnecessary therapeutic interventions.
引用
- Kumar SA, Pandit N, Srinivasan P, et al. False-positive ¹³¹I Uptake in a Carotid Body Tumor Mimicking Nodal Metastasis in Differentiated Thyroid Carcinoma: Implications of Hybrid SPECT/CT. Clin Nucl Med. 2026. PMID: 41954972. doi:10.1097/RLU.0000000000006436
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。